Status:
TERMINATED
Quality of Life and Cancers in Nursing Homes
Lead Sponsor:
University Hospital, Caen
Conditions:
Quality of Life
Cancer
Eligibility:
All Genders
70+ years
Phase:
NA
Brief Summary
Quality of life (QOL) of nursing homes residents with cancer in France is not known. High prevalence of neurodegenerative diseases makes it difficult. It was found that oncological management is subop...
Detailed Description
Investigators will also make a descriptive inventory of the oncological care and support care in these patients, in order to evaluate the need for a specific oncogeriatric intervention. Quality of li...
Eligibility Criteria
Inclusion
- Affiliated to the social security system
- talking french language
- Cancer group: All residents with a history of cancer,
- Control group: residents without any history of cancer (same number of residents as in the cancer group), randomly selected in each nursing home, matched to age, sex, presence of dementia (mild or Moderate), and AGGIR dependancy scale
Exclusion
- Severe dementia (MMS \<10/30) • Total disability to communicate
Key Trial Info
Start Date :
July 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 9 2020
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT03343210
Start Date
July 18 2018
End Date
July 9 2020
Last Update
October 7 2021
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Amiens UH
Amiens, France
2
Caen UH
Caen, France
3
Pasteur HC
Cherbourg, France
4
Fecamp HC
Fécamp, France